🇺🇸 FDA
Patent

US 8921097

Methods for expression and purification of immunotoxins

granted A61KA61K47/6829A61K47/6849

Quick answer

US patent 8921097 (Methods for expression and purification of immunotoxins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K47/6829, A61K47/6849